Sergey Leonov received his MD in Biochemistry and Molecular Biology from Russian State Medical University in 1980 and a Ph.D. in Molecular Virology from The D.I. Ivanovskii Institute of Virology in 1991. He has more than 20 years of experience in drug discovery in Biotech and global pharmaceutical companies. He focused on Oncology, Neuroscience, and Pharmacology. Now, he is a Principal Scientist in the Laboratory of personalized radio-chemotherapy at the Institute of Future Biophysics, Dolgoprudny, Russia. His research interests mainly focus on Cancer Stem cell radioresistance, DNA damage and repair, Mechanobiology of cancer, and Molecular mechanisms of neurodegeneration/ neuroinflammation/cancerogenesis.
Sergey Leonov received his MD in Biochemistry and Molecular Biology from Russian State Medical University in 1980 and a Ph.D. in Molecular Virology from The D.I. Ivanovskii Institute of Virology in 1991. He has more than 20 years of experience in drug discovery in Biotech and global pharmaceutical companies. He focused on Oncology, Neuroscience, and Pharmacology. Now, he is a Principal Scientist in the Laboratory of personalized radio-chemotherapy at the Institute of Future Biophysics, Dolgoprudny, Russia. His research interests mainly focus on Cancer Stem cell radioresistance, DNA damage and repair, Mechanobiology of cancer, and Molecular mechanisms of neurodegeneration/ neuroinflammation/cancerogenesis.